CDKN1B nuclear expression was clearly reduced in an in situ carcinoma (Figure 4B, E) and almost absent in an adenocarcinoma (Figure 4C, F) from Men1+/- mice. The gene discussed is CDKN1B; the disease is in situ carcinoma.